Terapia grypy

Journal Title: Farmacja Polska - Year 2010, Vol 66, Issue 1

Abstract

Medical therapy of influenza has been usually based on alleviation of symptoms. From among the antiviral drugs the derivatives of adamantane have been mainly used, and since 1999 also neuraminidase inhibitors. The latter inhibitors act against the influenza viruses type A and B, while the adamantane derivatives are effective against the pathogen of influenza type A. The effectiveness of medical therapy is closely related to its early implementation – up to 48 hours since the appearance of the first symptoms.

Authors and Affiliations

Beata Stanisz

Keywords

Related Articles

Udział czynników endo- i egzogennych w indukowaniu hiperglikemii i glukotoksyczności – istotny problem XXI wieku w opiece nad pacjentem

The participation of endo- and exogenous agents in the induction of hyperglycemia and glucotoxicity – an important problem in the XXI century patient care • Glucotoxicity induced by hyperglycemia is related with its nega...

Wywiad motywujący w praktyce aptekarza. Jak farmaceuta może wspierać pacjenta w prozdrowotnej zmianie?

Motivational interviewing in pharmacy practice: How pharmacists can help patients in healthy change ・ Pharmacist can support patients to develop healthy habits and model health attitudes and behavior. This paper aims to...

Dextrometorphan - a drug characteristics

Dextromethorphan is an effective antitussive agent for treating uncomplicated, nonproductive cough. Dextromethorphan is as effective as codeine. The advantages of dextromethorphan compared to codeine include a lower rate...

Opracowanie aktów delegowanych do dyrektywy ds. leków sfałszowanych (Falsified Medicines Directive) dla polskiego systemu ochrony zdrowia, ze wskazaniem najważniejszych zmian w Prawie Farmaceutycznym

Falsified Medicines Directive (FMD) "Delegated Act" - non-official translation, commentary and impact on Polish pharmaceutical law ・ Herein, we present an authorial translation of an original text of delegated acts of F...

Leki jako czynniki ryzyka rozwoju hiperglikemii oraz mechanizmy ich działania diabetogennego

Glukotoksyczność indukowana hiperglikemią dotyczy negatywnego jej wpływu na szlaki metaboliczne i struktury komórkowe organizmu. Szczególnie wrażliwe na toksyczne działanie hiperglikmeii są komórki beta wysp Langerhansa...

Download PDF file
  • EP ID EP69853
  • DOI -
  • Views 95
  • Downloads 0

How To Cite

Beata Stanisz (2010). Terapia grypy. Farmacja Polska, 66(1), 9-14. https://europub.co.uk/articles/-A-69853